{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:23:10Z","timestamp":1790518990957,"version":"4.1.0"},"update-to":[{"DOI":"10.1371\/journal.pntd.0007653","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T00:00:00Z","timestamp":1566864000000}}],"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T00:00:00Z","timestamp":1565827200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","award":["ID OPP53460"],"award-info":[{"award-number":["ID OPP53460"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0007653","type":"journal-article","created":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T17:50:42Z","timestamp":1565891442000},"page":"e0007653","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Relationship between treatment regimens for visceral leishmaniasis and development of post-kala-azar dermal leishmaniasis and visceral leishmaniasis relapse: A cohort study from Bangladesh"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9154-8327","authenticated-orcid":true,"given":"Dinesh","family":"Mondal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amresh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshtaq Mural","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Golam","family":"Hasnain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Alim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Mamun","family":"Huda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ridwanur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Alvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Be-Nazir","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashidul","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,8,15]]},"reference":[{"issue":"3","key":"pntd.0007653.ref001","first-page":"275","article-title":"The epidemiology of visceral leishmaniasis in Bangladesh: prospects for improved control","volume":"123","author":"C Bern","year":"2006","journal-title":"Indian J Med Res"},{"issue":"8","key":"pntd.0007653.ref002","doi-asserted-by":"crossref","first-page":"e3020","DOI":"10.1371\/journal.pntd.0003020","article-title":"How far are we from visceral leishmaniasis elimination in Bangladesh? An assessment of epidemiological surveillance data","volume":"8","author":"R Chowdhury","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0007653.ref003","volume-title":"Regional strategic framework for elimination of kala-azar from the South-East Asia region (2005\u20132015)","author":"World Health Organization (WHO) Regional Office for South-East Asia (SEARO)"},{"key":"pntd.0007653.ref004","unstructured":"World Health Organization (WHO). Accelerating work to overcome the global impact of neglected tropical diseases: a roadmap for implementation. Geneva: WHO; 2012: pp. 1\u201337. https:\/\/www.who.int\/neglected_diseases\/NTD_RoadMap_2012_Fullversion.pdf (accessed March, 24, 2019)."},{"key":"pntd.0007653.ref005","doi-asserted-by":"crossref","first-page":"e304","DOI":"10.1016\/S1473-3099(16)30140-2","article-title":"Elimination of visceral leishmaniasis on the Indian subcontinent","volume":"16","author":"OP Singh","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"pntd.0007653.ref006","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1473-3099(03)00517-6","article-title":"Post-kala-azar dermal leishmaniasis","volume":"3","author":"EE Zijlstra","year":"2003","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"pntd.0007653.ref007","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4269\/ajtmh.12-0711","article-title":"Clinical and immunological aspects of post-kala-azar dermal leishmaniasis in Bangladesh","volume":"89","author":"S Islam","year":"2013","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"pntd.0007653.ref008","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/cid\/cix245","article-title":"Infectivity of post-kala-azar dermal leishmaniasis patients to sand flies: revisiting a proof of concept in the context of the kala-azar elimination program in the Indian subcontinent","volume":"65","author":"R Molina","year":"2017","journal-title":"Clin Infect Dis"},{"key":"pntd.0007653.ref009","article-title":"Quantifying the infectiousness of post-kala-azar dermal leishmaniasis towards sandflies","author":"D Mondal","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"11","key":"pntd.0007653.ref010","doi-asserted-by":"crossref","first-page":"e0005877","DOI":"10.1371\/journal.pntd.0005877","article-title":"Post-kala-azar dermal leishmaniasis in the Indian subcontinent: a threat to the South-East Asia Region Kala-azar Elimination Programme","volume":"11","author":"EE Zijlstra","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"pntd.0007653.ref011","doi-asserted-by":"crossref","first-page":"e0185606","DOI":"10.1371\/journal.pone.0185606","article-title":"Real-time PCR in detection and quantitation of Leishmania donovani for the diagnosis of Visceral Leishmaniasis patients and the monitoring of their response to treatment","volume":"12","author":"F Hossain","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"pntd.0007653.ref012","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s40249-018-0461-0","article-title":"Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh\u2019s National Kala-azar Elimination Programme","volume":"7","author":"MS Hossain","year":"2018","journal-title":"Infect Dis Poverty"},{"issue":"12","key":"pntd.0007653.ref013","doi-asserted-by":"crossref","first-page":"e1433","DOI":"10.1371\/journal.pntd.0001433","article-title":"Post-kala-azar dermal leishmaniasis in Nepal: a retrospective cohort study (2000\u20132010)","volume":"5","author":"S Uranw","journal-title":"PLoS Negl Trop Dis 2011"},{"issue":"10","key":"pntd.0007653.ref014","doi-asserted-by":"crossref","first-page":"e0005060","DOI":"10.1371\/journal.pntd.0005060","article-title":"Chronic arsenic exposure and risk of post kala-azar dermal leishmaniasis development in India: a retrospective cohort study","volume":"10","author":"S Das","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"pntd.0007653.ref015","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1159\/000272457","article-title":"Interleukin 10 gene polymorphisms and development of post kala-azar dermal leishmaniasis in a selected Sudanese population","volume":"13","author":"S Farouk","year":"2010","journal-title":"Public Health Genomics"},{"issue":"1","key":"pntd.0007653.ref016","first-page":"10","article-title":"PKDL\u2014a drug related phenomenon?","volume":"128","author":"SL Croft","year":"2008","journal-title":"Indian J Med Res"},{"issue":"3","key":"pntd.0007653.ref017","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4103\/0019-5154.110848","article-title":"Post-kala-azar dermal leishmaniasis developing in miltefosine-treated visceral leishmaniasis","volume":"58","author":"S Koley","year":"2013","journal-title":"Indian J Dermatol"},{"issue":"4","key":"pntd.0007653.ref018","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1128\/JCM.05966-11","article-title":"Post-kala-azar dermal leishmaniasis in a patient treated with injectable paromomycin for visceral leishmaniasis in India","volume":"50","author":"K Pandey","year":"2012","journal-title":"J Clin Microbiol"},{"issue":"3","key":"pntd.0007653.ref019","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4103\/0022-3859.118046","article-title":"Development of post-kala-azar dermal leishmaniasis in AmBisome treated visceral leishmaniasis: a possible challenge to elimination program in India","volume":"59","author":"VN Das","year":"2013","journal-title":"J Postgrad Med"},{"issue":"1","key":"pntd.0007653.ref020","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/S2214-109X(13)70118-9","article-title":"Efficacy and safety of single-dose liposomal amphotericin B for visceral leishmaniasis in a rural public hospital in Bangladesh: a feasibility study","volume":"2","author":"D Mondal","year":"2014","journal-title":"Lancet Glob Health"},{"key":"pntd.0007653.ref021","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1056\/NEJMoa0903627","article-title":"Single-dose liposomal amphotericin B for visceral leishmaniasis in India","volume":"362","author":"S Sundar","year":"2010","journal-title":"N Engl J Med"},{"issue":"5","key":"pntd.0007653.ref022","doi-asserted-by":"crossref","first-page":"e0005635","DOI":"10.1371\/journal.pntd.0005635","article-title":"Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh","volume":"11","author":"R Rahman","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"pntd.0007653.ref023","doi-asserted-by":"crossref","first-page":"e0004118","DOI":"10.1371\/journal.pntd.0004118","article-title":"Effectiveness study of Paromomycin IM Injection (PMIM) for the treatment of visceral leishmaniasis (VL) in Bangladesh","volume":"9","author":"KM Jamil","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0007653.ref024","unstructured":"Ahmed B-N, chief ed. National guideline for kala-azar case management May, 2013. Dhaka: Kala-azar Elimination Program, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of the Peoples Republic of Bangladesh; 2013. pp. 5\u201312. http:\/\/kalacorebd.com\/wp-content\/uploads\/2016\/04\/KA-Managment-Guideline-18-05-2013_v10-1.pdf (accessed March, 24, 2019)."},{"key":"pntd.0007653.ref025","volume-title":"Control of the leishmaniases: report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, 22\u201326 March 2010","year":"2010"},{"issue":"1","key":"pntd.0007653.ref026","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4269\/ajtmh.2011.10-0661","article-title":"Phase IV trial of miltefosine in adults and children for treatment of visceral leishmaniasis (kala-azar) in Bangladesh","volume":"85","author":"M Rahman","year":"2011","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"pntd.0007653.ref027","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1086\/519690","article-title":"Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis","volume":"196","author":"SK Bhattacharya","year":"2007","journal-title":"J Infect Dis"},{"issue":"1","key":"pntd.0007653.ref028","doi-asserted-by":"crossref","first-page":"e355","DOI":"10.1371\/journal.pntd.0000355","article-title":"Visceral leishmaniasis elimination programme in India, Bangladesh, and Nepal: Reshaping the case finding\/case management strategy","volume":"3","author":"D Mondal","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0007653.ref029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.02009-17","article-title":"Relation between skin pharmacokinetics and efficacy in AmBisome treatment of murine cutaneous leishmaniasis","volume":"62","author":"GJ Wijnant","year":"2018","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"1","key":"pntd.0007653.ref030","doi-asserted-by":"crossref","first-page":"e2611","DOI":"10.1371\/journal.pntd.0002611","article-title":"Post Kala-Azar dermal leishmaniasis following treatment with 20 mg\/kg liposomal amphotericin B (Ambisome) for primary visceral leishmaniasis in Bihar, India","volume":"8","author":"S Burza","year":"2014","journal-title":"PLoS Negl Trop Dis"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0007653","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T00:00:00Z","timestamp":1566864000000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0007653","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T19:04:05Z","timestamp":1664132645000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0007653"}},"subtitle":[],"editor":[{"given":"Jesus G.","family":"Valenzuela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,8,15]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0007653","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0007653","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,15]]}}}